📰 Nasdaq Bblg News
Nasdaq Bblg News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Bblg. Real-time updates on events, politics, business and more.
April 9, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) and Avanos Medical (NYSE:AVNS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, valuation, dividends, institutional ownership and analyst recommendations. Profitability This table compares Bone Biologics and […]
March 29, 2024
Bone Biologics Co. (NASDAQ:BBLG – Get Free Report) was the target of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 31,100 shares, a decline of 75.1% from the February 29th total of 124,800 shares. Based on an average daily trading volume, of 263,900 […]
January 27, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 48 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it contrast to its competitors? We will compare Bone Biologics to similar companies based on the strength of its dividends, institutional ownership, analyst recommendations, profitability, earnings, valuation and risk. Insider and Institutional […]
January 27, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 51 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its competitors? We will compare Bone Biologics to related companies based on the strength of its earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations. Volatility […]
January 27, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 51 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its peers? We will compare Bone Biologics to similar businesses based on the strength of its analyst recommendations, valuation, risk, institutional ownership, dividends, earnings and profitability. Insider & Institutional […]
January 22, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) and Milestone Scientific (NYSE:MLSS – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, analyst recommendations, risk, institutional ownership, profitability and earnings. Analyst Recommendations This is a breakdown of […]
January 18, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 50 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its rivals? We will compare Bone Biologics to related businesses based on the strength of its earnings, profitability, valuation, analyst recommendations, dividends, institutional ownership and risk. Volatility […]
January 17, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 51 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it compare to its competitors? We will compare Bone Biologics to similar companies based on the strength of its profitability, dividends, earnings, valuation, analyst recommendations, risk and institutional ownership. Volatility and Risk […]
January 10, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 49 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its rivals? We will compare Bone Biologics to related companies based on the strength of its analyst recommendations, earnings, risk, institutional ownership, profitability, dividends and valuation. Earnings […]
January 8, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) is one of 49 public companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its peers? We will compare Bone Biologics to related businesses based on the strength of its valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk. Valuation […]